WHO advises 2 monoclonal antibodies for severe COVID

Jul 06, 2021

Study finds that tocilizumab and sarilumab reduce the risk of death and the need for mechanical ventilation.

Lisa Schnirring | News Editor | CIDRAP News

Jul 06, 2021
Study finds that tocilizumab and sarilumab reduce the risk of death and the need for mechanical ventilation.Read More

Leave a Reply

Your email address will not be published.